Home > Publications database > Functional imaging studies of acute administration of classic psychedelics, ketamine, and MDMA: Methodological limitations and convergent results > print

001     1017815
005     20240429104845.0
024 7 _ |a 10.1016/j.neubiorev.2023.105421
|2 doi
024 7 _ |a 0149-7634
|2 ISSN
024 7 _ |a 1873-7528
|2 ISSN
024 7 _ |a 37802267
|2 pmid
024 7 _ |a WOS:001099598200001
|2 WOS
037 _ _ |a FZJ-2023-04348
082 _ _ |a 610
100 1 _ |a Linguiti, Sophia
|0 P:(DE-HGF)0
|b 0
245 _ _ |a Functional imaging studies of acute administration of classic psychedelics, ketamine, and MDMA: Methodological limitations and convergent results
260 _ _ |a Amsterdam [u.a.]
|c 2023
|b Elsevier Science
336 7 _ |a Output Types/Book Review
|2 DataCite
336 7 _ |a Review
|b review
|m review
|0 PUB:(DE-HGF)36
|s 1712664197_18041
|2 PUB:(DE-HGF)
336 7 _ |a BOOK_REVIEW
|2 ORCID
336 7 _ |a review
|2 DRIVER
336 7 _ |a Journal Article
|0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
|m journal
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Functional magnetic resonance imaging (fMRI) is increasingly used to non-invasively study the acute impact of psychedelics on the human brain. While fMRI is a promising tool for measuring brain function in response to psychedelics, it also has known methodological challenges. We conducted a systematic review of fMRI studies examining acute responses to experimentally administered psychedelics in order to identify convergent findings and characterize heterogeneity in the literature. We reviewed 91 full-text papers; these studies were notable for substantial heterogeneity in design, task, dosage, drug timing, and statistical approach. Data recycling was common, with 51 unique samples across 91 studies. Fifty-seven studies (54%) did not meet contemporary standards for Type I error correction or control of motion artifact. Psilocybin and LSD were consistently reported to moderate the connectivity architecture of the sensorimotor-association cortical axis. Studies also consistently reported that ketamine administration increased activation in the dorsomedial prefrontal cortex. Moving forward, use of best practices such as pre-registration, standardized image processing and statistical testing, and data sharing will be important in this rapidly developing field.
536 _ _ |a 5253 - Neuroimaging (POF4-525)
|0 G:(DE-HGF)POF4-5253
|c POF4-525
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: juser.fz-juelich.de
700 1 _ |a Vogel, Jacob W.
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Sydnor, Valerie J.
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Pines, Adam
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Wellman, Nick
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Basbaum, Allan
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Eickhoff, Claudia
|0 P:(DE-Juel1)174483
|b 6
700 1 _ |a Eickhoff, Simon B.
|0 P:(DE-Juel1)131678
|b 7
700 1 _ |a Edwards, Robert R.
|0 P:(DE-HGF)0
|b 8
700 1 _ |a Larsen, Bart
|0 P:(DE-HGF)0
|b 9
700 1 _ |a McKinstry-Wu, Andrew
|0 P:(DE-HGF)0
|b 10
700 1 _ |a Scott, J. Cobb
|0 P:(DE-HGF)0
|b 11
700 1 _ |a Roalf, David R.
|0 P:(DE-HGF)0
|b 12
700 1 _ |a Sharma, Vaishnavi
|0 P:(DE-HGF)0
|b 13
700 1 _ |a Strain, Eric C.
|0 P:(DE-HGF)0
|b 14
700 1 _ |a Corder, Gregory
|0 P:(DE-HGF)0
|b 15
700 1 _ |a Dworkin, Robert H.
|0 P:(DE-HGF)0
|b 16
700 1 _ |a Satterthwaite, Theodore D.
|0 P:(DE-HGF)0
|b 17
|e Corresponding author
773 _ _ |a 10.1016/j.neubiorev.2023.105421
|g Vol. 154, p. 105421 -
|0 PERI:(DE-600)1498433-7
|p 105421 -
|t Neuroscience & biobehavioral reviews
|v 154
|y 2023
|x 0149-7634
909 C O |o oai:juser.fz-juelich.de:1017815
|p VDB
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 7
|6 P:(DE-Juel1)131678
910 1 _ |a HHU Düsseldorf
|0 I:(DE-HGF)0
|b 7
|6 P:(DE-Juel1)131678
913 1 _ |a DE-HGF
|b Key Technologies
|l Natural, Artificial and Cognitive Information Processing
|1 G:(DE-HGF)POF4-520
|0 G:(DE-HGF)POF4-525
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-500
|4 G:(DE-HGF)POF
|v Decoding Brain Organization and Dysfunction
|9 G:(DE-HGF)POF4-5253
|x 0
914 1 _ |y 2023
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2023-10-21
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-10-21
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1120
|2 StatID
|b BIOSIS Reviews Reports And Meetings
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-10-21
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NEUROSCI BIOBEHAV R : 2022
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-10-21
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-10-21
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b NEUROSCI BIOBEHAV R : 2022
|d 2023-10-21
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-7-20090406
|k INM-7
|l Gehirn & Verhalten
|x 0
920 1 _ |0 I:(DE-Juel1)INM-1-20090406
|k INM-1
|l Strukturelle und funktionelle Organisation des Gehirns
|x 1
980 _ _ |a review
980 _ _ |a VDB
980 _ _ |a journal
980 _ _ |a I:(DE-Juel1)INM-7-20090406
980 _ _ |a I:(DE-Juel1)INM-1-20090406
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21